相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Apolipoprotein M in lipid metabolism and cardiometabolic diseases
Anna Borup et al.
CURRENT OPINION IN LIPIDOLOGY (2015)
Catalytic Stimulation by Restrained Active-Site Floppiness-The Case of High Density Lipoprotein-Bound Serum Paraoxonase-1
Moshe Ben-David et al.
JOURNAL OF MOLECULAR BIOLOGY (2015)
Serum myeloperoxidase/paraoxonase 1 ratio as potential indicator of dysfunctional high-density lipoprotein and risk stratification in coronary artery disease
Yoko Haraguchi et al.
ATHEROSCLEROSIS (2014)
Thematic Review Series: High Density Lipoprotein Structure, Function, and Metabolism Cardioprotective functions of HDLs
Kerry-Anne Rye et al.
JOURNAL OF LIPID RESEARCH (2014)
Human Paraoxonase 1 as a Pharmacologic Agent: Limitations and Perspectives
Priyanka Bajaj et al.
TheScientificWorldJOURNAL (2014)
Lipid complex of apolipoprotein A-I mimetic peptide 4F is a novel platform for paraoxonase-1 binding and enhancing its activity and stability
Vinod K. Mishra et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
High-density lipoprotein impedes glycation of low-density lipoprotein
Nahla N. Younis et al.
DIABETES & VASCULAR DISEASE RESEARCH (2013)
Myeloperoxidase, paraoxonase-1, and HDL form a functional ternary complex
Ying Huang et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Association of paraoxonase gene polymorphisms with diabetic nephropathy and retinopathy
Jun Wang et al.
MOLECULAR MEDICINE REPORTS (2013)
Lipid Oxidation in Carriers of Lecithin: Cholesterol Acyltransferase Gene Mutations
Adriaan G. Holleboom et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2012)
Apolipoprotein M binds oxidized phospholipids and increases the antioxidant effect of HDL
Sara Elsoe et al.
ATHEROSCLEROSIS (2012)
Quantitative Assessment of the Influence of Paraoxonase 1 Activity and Coronary Heart Disease Risk
Mingsong Wang et al.
DNA AND CELL BIOLOGY (2012)
Phospholipase A2 enzymes and the risk of atherosclerosis
Robert S. Rosenson et al.
EUROPEAN HEART JOURNAL (2012)
Antioxidant and anti-inflammatory role of paraoxonase 1: Implication in arteriosclerosis diseases
Dmitry Litvinov et al.
NORTH AMERICAN JOURNAL OF MEDICAL SCIENCES (2012)
Injection of paraoxonase 1 (PON1) to mice stimulates their HDL and macrophage antiatherogenicity
Mira Rosenblat et al.
BIOFACTORS (2011)
History of Discovery Oxidized Low-Density Lipoprotein and Atherosclerosis
Daniel Steinberg et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2010)
Antiatherogenic function of HDL particle subpopulations: focus on antioxidative activities
Anatol Kontush et al.
CURRENT OPINION IN LIPIDOLOGY (2010)
Small-dense LDL and LDL glycation in metabolic syndrome and in statin-treated and non-statin-treated type 2 diabetes
Nahla N. Younis et al.
DIABETES & VASCULAR DISEASE RESEARCH (2010)
Studies on protective effects of human paraoxonases 1 and 3 on atherosclerosis in apolipoprotein E knockout mice
C. Zhang et al.
GENE THERAPY (2010)
Glycation of LDL in non-diabetic people: Small dense LDL is preferentially glycated both in vivo and in vitro
Nahla Younis et al.
ATHEROSCLEROSIS (2009)
Variation in paraoxonase-1 activity and atherosclerosis
Handrean Soran et al.
CURRENT OPINION IN LIPIDOLOGY (2009)
Paraoxonase 1 (PON1) attenuates diabetes development in mice through its antioxidative properties
Orit Rozenberg et al.
FREE RADICAL BIOLOGY AND MEDICINE (2008)
Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular risk
Tamali Bhattacharyya et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Association between PON 1 polymorphisms, PON activity and diabetes complications
Sabine E. Hofer et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2006)
Human paraoxonases (PON1, PON2, and PON3) are lactonases with overlapping and distinct substrate specificities
DI Draganov et al.
JOURNAL OF LIPID RESEARCH (2005)
Structure and evolution of the serum paraoxonase family of detoxifying and anti-atherosclerotic enzymes
M Harel et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2004)
Four paraoxonase gene polymorphisms in 11,212 cases of coronary heart disease and 12,786 controls: meta-analysis of 43 studies
JG Wheeler et al.
LANCET (2004)
Role of oxidative modifications in atherosclerosis
R Stocker et al.
PHYSIOLOGICAL REVIEWS (2004)
Low paraoxonase activity predicts coronary events in the caerphilly prospective study
B Mackness et al.
CIRCULATION (2003)
Decreased atherosclerotic lesion formation in human serum paraoxonase transgenic mice
A Tward et al.
CIRCULATION (2002)
Serum paraoxonase activity in patients with type I diabetes compared to healthy controls
B Mackness et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2002)
Paraoxonase (PON1) polymorphisms in farmers attributing ill health to sheep dip
N Cherry et al.
LANCET (2002)
Paraoxonase status in coronary heart disease - Are activity and concentration more important than genotype?
B Mackness et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2001)
Paraoxonase and atherosclerosis
PN Durrington et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2001)
分享论文
